Gout Urate-Lowering Therapy: Indications & Targets — free guideline decision tool
This tool decides whether to start urate-lowering therapy (ULT) in gout and sets the serum-urate target, based on urate level and comorbidities per the 2019 Chinese hyperuricemia/gout guideline.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Gout Urate-Lowering Therapy: Indications & Targets do?
Use to determine ULT initiation and target: serum urate ≥ 480 µmol/L starts ULT, ≥ 420 with high-risk features starts ULT, and the target is < 360 (or < 300 with tophi/frequent flares).
How is the result calculated?
Initiate if urate ≥ 480, or ≥ 420 with flares ≥ 2/yr, tophi, nephrolithiasis, CKD, hypertension, diabetes, dyslipidemia, cardio-cerebrovascular disease, or onset < 40 yr. Target < 360 µmol/L; < 300 with severe disease; not chronically < 180.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Gout Urate-Lowering Therapy: Indications & Targets now
This tool decides whether to start urate-lowering therapy (ULT) in gout and sets the serum-urate target, based on urate level and comorbidities per the 2019 Chinese hyperuricemia/gout guideline.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.